411 related articles for article (PubMed ID: 20160534)
21. [Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].
Xing Y; Song HM; Wu XY; He YY; Wei M
Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):822-6. PubMed ID: 19099898
[TBL] [Abstract][Full Text] [Related]
22. Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2.
Humbert M; Coghlan JG; Ghofrani HA; Grimminger F; He JG; Riemekasten G; Vizza CD; Boeckenhoff A; Meier C; de Oliveira Pena J; Denton CP
Ann Rheum Dis; 2017 Feb; 76(2):422-426. PubMed ID: 27457511
[TBL] [Abstract][Full Text] [Related]
23. Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.
Cavagna L; Codullo V; Ghio S; Scirè CA; Guzzafame E; Scelsi L; Rossi S; Montecucco C; Caporali R
Medicine (Baltimore); 2016 Sep; 95(39):e4827. PubMed ID: 27684814
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary arterial hypertension in connective tissue diseases.
Mathai SC; Hassoun PM
Heart Fail Clin; 2012 Jul; 8(3):413-25. PubMed ID: 22748903
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary hypertension in connective tissue diseases: an update.
Aithala R; Alex AG; Danda D
Int J Rheum Dis; 2017 Jan; 20(1):5-24. PubMed ID: 28205373
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension.
Rhee RL; Gabler NB; Sangani S; Praestgaard A; Merkel PA; Kawut SM
Am J Respir Crit Care Med; 2015 Nov; 192(9):1111-7. PubMed ID: 26291092
[TBL] [Abstract][Full Text] [Related]
27. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.
Kuwana M; Blair C; Takahashi T; Langley J; Coghlan JG
Ann Rheum Dis; 2020 May; 79(5):626-634. PubMed ID: 32161055
[TBL] [Abstract][Full Text] [Related]
28. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.
Hachulla E; Coghlan JG
Ann Rheum Dis; 2004 Sep; 63(9):1009-14. PubMed ID: 15308510
[TBL] [Abstract][Full Text] [Related]
29. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.
Kimura M; Tamura Y; Takei M; Yamamoto T; Ono T; Fujita J; Kataoka M; Kuwana M; Satoh T; Fukuda K
BMC Pulm Med; 2015 May; 15():62. PubMed ID: 25971443
[TBL] [Abstract][Full Text] [Related]
30. Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
Sargent T; Tsang Y; Panjabi S; Funtanilla V; Germack HD; Gauthier-Loiselle M; Manceur AM; Cloutier M; Lefebvre P
Adv Ther; 2023 Nov; 40(11):5037-5054. PubMed ID: 37728697
[TBL] [Abstract][Full Text] [Related]
31. Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases.
Cozzi F; Montisci R; Marotta H; Bobbo F; Durigon N; Ruscazio M; Sfriso P; Iliceto S; Todesco S
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():49-53. PubMed ID: 16919011
[TBL] [Abstract][Full Text] [Related]
32. 2009 ESC/ERS pulmonary hypertension guidelines and connective tissue disease.
Nakanishi N; ;
Allergol Int; 2011 Dec; 60(4):419-24. PubMed ID: 22015568
[TBL] [Abstract][Full Text] [Related]
33. [Pulmonary arterial hypertension related to connective tissue diseases].
Pehlivan O; Inanç M
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():57-62. PubMed ID: 20819768
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary arterial hypertension related to connective tissue disease: a review.
Ahmed S; Palevsky HI
Rheum Dis Clin North Am; 2014 Feb; 40(1):103-24. PubMed ID: 24268012
[TBL] [Abstract][Full Text] [Related]
35. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
Kato M; Kataoka H; Odani T; Fujieda Y; Otomo K; Oku K; Horita T; Yasuda S; Atsumi T; Ohira H; Tsujino I; Nishimura M; Koike T
Lupus; 2011 Oct; 20(10):1047-56. PubMed ID: 21676917
[TBL] [Abstract][Full Text] [Related]
36. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
Oudiz RJ; Schilz RJ; Barst RJ; Galié N; Rich S; Rubin LJ; Simonneau G;
Chest; 2004 Aug; 126(2):420-7. PubMed ID: 15302727
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis.
Li M; Jing ZC; Li Y; Huo Y; Yu Z; Zhang G; Zhu P; Liu J; Ji Q; Wu B; Zhong J; Wang P; Zhu W; Zeng X
BMC Cardiovasc Disord; 2020 Jul; 20(1):339. PubMed ID: 32680480
[TBL] [Abstract][Full Text] [Related]
38. [Pulmonary arterial hypertension in connective tissue diseases].
Cordier JF
Bull Acad Natl Med; 2009 Nov; 193(8):1911-8; discussion 1918-9. PubMed ID: 20669554
[TBL] [Abstract][Full Text] [Related]
39. Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center.
Shirai Y; Yasuoka H; Takeuchi T; Satoh T; Kuwana M
Mod Rheumatol; 2013 Nov; 23(6):1211-20. PubMed ID: 23359006
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review.
Bazan IS; Mensah KA; Rudkovskaia AA; Adonteng-Boateng PK; Herzog EL; Buckley L; Fares WH
Respir Med; 2018 Jan; 134():42-46. PubMed ID: 29413506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
